Click here to go to the previous page
Germany: Biotech "Made in Germany": From Start-up to Grown-up
Program Code:
IS1120
Date:
Sunday, May 6, 2007
Time:
2:00 PM to 3:30 PM
CHAIR
(S):
Terry C. Martin, Journalist
Viola Bronsema, Managing Director, BIO Deutschland e.V.
SPEAKER
(S):
Steffen Helmling
Günther Wess
Thomas Christély, CEO, atugen AG
Peter J.W. Stadler, CEO, Artemis Pharmaceuticals GmbH
Description
In 2006 once again Germany ranked number 1 in biotech companies in Europe. Knowledgeable and experienced entrepreneurs shaping Germany's biotech landscape today will share their experience and create a German vision for the years to come.
Objectives:
Describe the German biotechnology industry: product focus, maturation and creative financing.
Explain how government support fuels growth along the whole company life cycle.
Have German entrepreneurs and industry experts share their vision of business opportunities in Germany.